Health Care: Drugs

MannKind Corp (MNKD: NASDAQ)

$1.82 -0.07 | -3.7%
03/27/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.89
52 Week High 10.60
52 Week Low 1.74
Avg. Daily Vol. (Mil) 1.11
Beta (3 year) 2.88
Share Related Items
Mkt Cap (Mil) 181.02
Shares Out (Mil) 95.78
Float (Mil) 73.42
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.60
Current Ratio 0.80
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings 1.40
Price/Sales 1.04
Price/Book 0.00
Price/Cash Flow 1.40
Per Share Data
Earnings 1.36
Sales 1.82
Book Value 0.00
Cash Flow 1.36
Business Summary
MannKind Corp is a development stage company engaged in the discovery, development, and commercialization of therapeutic products for diseases such as diabetes.
General Information
25134 Rye Canyon Loop
Suite 300
Valencia, CA 91355
www.mannkindcorp.com
Industry : Drugs
Sector: Health Care
Employees: 153
CEO: Matthew J. Pfeffer
Short Interest
Current Month (Mil) 19.79
Previous Month (Mil) 105.13
Short Interest Ratio (Days) 16.20
Management Effectiveness
Return on Equity n.a.
Return on Assets 117.40
Return on Investments -118.10
Profitability
Gross Margin 73.70
EBIT Margin 82.50
Profit Margin 71.90

Portfolios with MNKD

Latest MNKD Headlines from TheStreet

More Financial News for MNKD

Press Releases for MNKD

See All Press Releases

Partner Headlines for MNKD

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter